Results 211 to 220 of about 569,278 (268)

Health economic considerations for pharmacogenomic services in the United Kingdom: The Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics

open access: yes
British Journal of Clinical Pharmacology, EarlyView.
Dyfrig A. Hughes   +4 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Respiratory Syncytial Virus

Seminars in Respiratory and Critical Care Medicine, 2021
AbstractHuman respiratory syncytial virus (RSV) is a negative sense single-stranded RNA virus that can result in epidemics of seasonal respiratory infections. Generally, one of the two genotypes (A and B) predominates in a single season and alternate annually with regional variation. RSV is a known cause of disease and death at both extremes of ages in
Hannah H, Nam, Michael G, Ison
openaire   +2 more sources

Respiratory Syncytial Virus

Infection Control & Hospital Epidemiology, 1988
Respiratory syncytial virus (RSV) is the most important cause of lower respiratory tract infection in outpatients, as well as the major viral cause of nosocomial illness in pediatric inpatients. Immunity to this common pathogen is short lived and reinfection can occur later in life, even into adulthood.
J T, Sinnott, L S, Gilchrist, L, Ellis
openaire   +2 more sources

Home - About - Disclaimer - Privacy